Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) EBT (2020 - 2025)

Historic EBT for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$2.3 million.

  • Burning Rock Biotech's EBT rose 5410.58% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.9 million, marking a year-over-year increase of 7326.34%. This contributed to the annual value of -$46.7 million for FY2024, which is 4910.99% up from last year.
  • Per Burning Rock Biotech's latest filing, its EBT stood at -$2.3 million for Q3 2025, which was up 5410.58% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's EBT registered a high of -$1.3 million during Q2 2025, and its lowest value of -$41.2 million during Q1 2022.
  • Over the past 5 years, Burning Rock Biotech's median EBT value was -$23.9 million (recorded in 2023), while the average stood at -$21.7 million.
  • Its EBT has fluctuated over the past 5 years, first crashed by 21115.64% in 2021, then soared by 9110.51% in 2025.
  • Over the past 5 years, Burning Rock Biotech's EBT (Quarter) stood at -$39.6 million in 2021, then increased by 21.51% to -$31.1 million in 2022, then increased by 26.96% to -$22.7 million in 2023, then surged by 54.14% to -$10.4 million in 2024, then soared by 77.66% to -$2.3 million in 2025.
  • Its EBT was -$2.3 million in Q3 2025, compared to -$1.3 million in Q2 2025 and -$1.8 million in Q1 2025.